IL1B and cancer: The levels of IL-1β protein in the cancer-inoculated regions were then measured by ELISA, which revealed that the administration of sulfated CCK-8 increased the amount of IL-1β protein compared with that of the vehicle-treated control group (p < 0.01) (Figure 7).